# Clinical Evaluation of BW430C in Epilepsy

> **NCT00395694** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 102 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** lamictal

## Key facts

- **NCT ID:** NCT00395694
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08-07
- **Primary completion:** 2009-03-01
- **Final completion:** 2009-03-26
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395694, "Clinical Evaluation of BW430C in Epilepsy". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00395694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*